Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways. [electronic resource]
Producer: 20131217Description: 300-9 p. digitalISSN:- 1095-8673
- Acute Lung Injury -- chemically induced
- Animals
- Anti-Inflammatory Agents -- chemistry
- Cell Line
- Cell Survival -- drug effects
- Disease Models, Animal
- Furocoumarins -- chemistry
- Interleukin-6 -- metabolism
- Lipopolysaccharides -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Macrophages -- cytology
- Male
- Mice
- Mice, Inbred BALB C
- NF-kappa B -- immunology
- Pneumonia -- chemically induced
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.